[Federal Register Volume 68, Number 58 (Wednesday, March 26, 2003)]
[Notices]
[Pages 14673-14674]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-7131]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Mental Health; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Mental Health Special 
Emphasis Panel, Drug Discovery Panel B.
    Date: March 27, 2003.
    Time: 8 a.m. to 12 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Select Bethesda, 8120 Wisconsin Ave., 
Bethesda, MD 20814.
    Contact Person: Peter J. Sheridan, PhD, Scientific Review 
Administrator, Division of Extramural Activities, National Institute 
of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., 
Room 6142, MSC 9606, Bethesda, MD 20892-9606, 301-443-1513, 
[email protected].
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute of Mental Health Special 
Emphasis Panel, Drug Discovery Panel D.
    Date: March 27, 2003.
    Time: 2:45 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Select Bethesda, 8120 Wisconsin Ave., 
Bethesda, MD 20814.
    Contact Person: Peter J. Sheridan, PhD, Scientific Review 
Administrator, Division of Extramural Activities, National Institute 
of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., 
Room 6142, MSC 9606, Bethesda, MD 20892-9606, 301-443-1513, 
[email protected].
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute of Mental Health Special 
Emphasis Panel, Drug Discovery Panel E.
    Date: March 27, 2003.
    Time: 5:15 p.m. to 7:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Select Bethesda, 8120 Wisconsin Ave., 
Bethesda, MD 20814.
    Contact Person: Peter J. Sheridan, PhD, Scientific Review 
Administrator, Division of Extramural Activities, National Institute 
of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., 
Room 6142, MSC 9606, Bethesda, MD 20892-9606, 301-443-1513, 
[email protected].
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute of Mental Health Special 
Emphasis Panel, Drug Discovery Panel C.
    Date: March 27, 2003.
    Time: 12:15 p.m. to 2:45 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Select Bethesda, 8120 Wisconsin Ave., 
Bethesda, MD 20814.
    Contact Person: Peter J. Sheridan, PhD, Scientific Review 
Administrator, Division of Extramural Activities, National Institute 
of Mental Health, NIH, Neuroscience Center,

[[Page 14674]]

6001 Executive Blvd., Room 6142, MSC 9606, Bethesda, MD 20892-9606, 
301-443-1513, [email protected].
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.242, 
Mental Health Research Grants; 93.281, Scientist Development Award, 
Scientist Development Award for Clinicians, and Research Scientist 
Award; 93.282, Mental Health National Research Service Awards for 
Research Training, National Institutes of Health, HHS)
    Dated: March 18, 2003.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 03-7131 Filed 3-25-03; 8:45 am]
BILLING CODE 4140-01-M